37.60
+1.39(+3.84%)
Currency In USD
| Previous Close | 36.21 |
| Open | 36.06 |
| Day High | 37.72 |
| Day Low | 35.26 |
| 52-Week High | 91.83 |
| 52-Week Low | 30.01 |
| Volume | 444,278 |
| Average Volume | 487,805 |
| Market Cap | 758.14M |
| PE | -3.68 |
| EPS | -10.21 |
| Moving Average 50 Days | 70.5 |
| Moving Average 200 Days | 61.98 |
| Change | 1.39 |
If you invested $1000 in Praxis Precision Medicines, Inc. (PRAX) since IPO date, it would be worth $90.17 as of March 12, 2025 at a share price of $37.6. Whereas If you bought $1000 worth of Praxis Precision Medicines, Inc. (PRAX) shares 3 years ago, it would be worth $229.76 as of March 12, 2025 at a share price of $37.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Praxis Precision Medicines to Participate in Five Upcoming Investor Conferences
GlobeNewswire Inc.
Mar 04, 2025 1:00 PM GMT
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders charact
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Feb 04, 2025 10:00 PM GMT
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characte
Praxis Precision Medicines to Present at Two February Investor Conferences
GlobeNewswire Inc.
Feb 03, 2025 10:00 PM GMT
BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characte